ProQR Therapeutics N : AGM 2024 Explanatory Notes

2024 ANNUAL GENERAL MEETING OF SHAREHOLDERS PROQR THERAPEUTICS N.V.


Explanatory Notes to the Agenda


ProQR Therapeutics N.V. | Zernikedreef 9...

Related Keywords

United States ,Belfast ,United Kingdom ,Amsterdam ,Noord Holland ,Netherlands ,Germany ,Dutch ,Gerard Platenburg ,Ajames Shannon ,Ernst Bayer ,Martin Maier ,Dinko Valerio ,Royal College Of Physicians ,Pisa Pharmaceuticals ,Supervisory Board Of The Company ,Leiden University ,Company Management Board ,Queen University Of Belfast ,Alnylam Pharmaceuticals ,Company The Supervisory Board ,International Practices ,Company The Management Board ,University Of Leiden ,Glaxosmithkline ,Genentech ,Allen Overy ,University Of Amsterdam ,Ionis Pharmaceuticals ,Salk Institute ,Research Development ,Global Head Of Pharma Development At Novartis ,Clinical Development At Sterling Winthrop Pharmaceuticals ,Nasdaq ,Development Officer ,Cerimon Pharmaceuticals ,Mannkind Corp ,General Meeting ,Wednesday May ,Management Board ,Annual Accounts ,Supervisory Board ,Chief Scientific Officer ,Chief Innovation Officer ,Chief Executive ,Chief Executive Officer ,Chief Development ,Senior Vice President Research ,Norganic Chemistry ,Professor Ernst ,Aescap Venture ,Molecular Genetics ,Dutch Biotech ,Galapagos Genomics ,Chief Medical Officer ,Global Head ,Pharma Development ,Senior Vice President ,Clinical Development ,Sterling Winthrop ,Kyowa Kirin ,Royal College ,Markets ,